Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 74

1.

Triple negative breast cancer - our experience and review.

Krishnamurthy S, Poornima R, Challa VR, Goud YG.

Indian J Surg Oncol. 2012 Mar;3(1):12-6. doi: 10.1007/s13193-012-0138-2. Epub 2012 Feb 25.

2.

[Treatment outcomes and clinicopathologic characteristics of advanced triple-negative breast cancer patients].

Zhang P, Xu BH, Ma F, Li Q, Yuan P, Wang JY, Zhang P.

Zhonghua Zhong Liu Za Zhi. 2011 May;33(5):381-4. Chinese.

PMID:
21875471
3.
4.

Comparison of invasive micropapillary and triple negative invasive ductal carcinoma of the breast.

Chen HL, Ding A.

Breast. 2015 Dec;24(6):723-31. doi: 10.1016/j.breast.2015.09.001. Epub 2015 Sep 19.

PMID:
26392199
5.

Outcome of 561 non-metastatic triple negative breast cancer patients: multi-center experience from Turkey.

Budakoglu B, Altundag K, Aksoy S, Kaplan MA, Ozdemir NY, Berk V, Ozkan M, Algin E, Kandemir N, Dogu GG, Harputluoglu H, Arslan UY, Coskun U, Isikdogan A, Oksuzoglu B.

J BUON. 2014 Oct-Dec;19(4):872-8.

PMID:
25536589
6.

c-Met and ERβ expression differences in basal-like and non-basal-like triple-negative breast cancer.

Ren X, Yuan L, Shen S, Wu H, Lu J, Liang Z.

Tumour Biol. 2016 Aug;37(8):11385-95. doi: 10.1007/s13277-016-5010-5. Epub 2016 Mar 11.

PMID:
26968553
7.

Local recurrences and distant metastases after breast-conserving surgery and radiation therapy for early breast cancer.

Touboul E, Buffat L, Belkacémi Y, Lefranc JP, Uzan S, Lhuillier P, Faivre C, Huart J, Lotz JP, Antoine M, Pène F, Blondon J, Izrael V, Laugier A, Schlienger M, Housset M.

Int J Radiat Oncol Biol Phys. 1999 Jan 1;43(1):25-38.

PMID:
9989511
8.

Androgen receptor-positive triple negative breast cancer: a unique breast cancer subtype.

McGhan LJ, McCullough AE, Protheroe CA, Dueck AC, Lee JJ, Nunez-Nateras R, Castle EP, Gray RJ, Wasif N, Goetz MP, Hawse JR, Henry TJ, Barrett MT, Cunliffe HE, Pockaj BA.

Ann Surg Oncol. 2014 Feb;21(2):361-7. doi: 10.1245/s10434-013-3260-7. Epub 2013 Sep 18.

PMID:
24046116
9.

[Patterns and risk factors of recurrence in triple-negative breast cancer].

Yu F, Zhang X, Zhang S, Liu J, Liu Y, Zhang J.

Zhonghua Yi Xue Za Zhi. 2014 Jul 22;94(28):2180-3. Chinese.

PMID:
25331467
10.

[Clinicopathologic features and prognosis of triple negative breast cancer].

Zhou T, Yang L, Ma GM, Li CX, Bai Y, Zhao JA, Wang XL, Geng CZ.

Zhonghua Yi Xue Za Zhi. 2009 Aug 25;89(32):2261-4. Chinese.

PMID:
20095338
11.

Tumor characteristics and recurrence patterns in triple negative breast cancer: a comparison between younger (<65) and elderly (≥65) patients.

Königsberg R, Pfeiler G, Klement T, Hammerschmid N, Brunner A, Zeillinger R, Singer C, Dittrich C.

Eur J Cancer. 2012 Nov;48(16):2962-8. doi: 10.1016/j.ejca.2012.04.019. Epub 2012 May 28.

PMID:
22647688
12.

Unique clinicopathological features of metaplastic breast carcinoma compared with invasive ductal carcinoma and poor prognostic indicators.

Song Y, Liu X, Zhang G, Song H, Ren Y, He X, Wang Y, Zhang J, Zhang Y, Sun S, Liang X, Sun Q, Pang D.

World J Surg Oncol. 2013 Jun 6;11:129. doi: 10.1186/1477-7819-11-129.

13.

Nottingham Prognostic Index in triple-negative breast cancer: a reliable prognostic tool?

Albergaria A, Ricardo S, Milanezi F, Carneiro V, Amendoeira I, Vieira D, Cameselle-Teijeiro J, Schmitt F.

BMC Cancer. 2011 Jul 15;11:299. doi: 10.1186/1471-2407-11-299.

14.

Clinical Characteristics and prognostic analysis of Triple-negative Breast Cancer: Single institute experience.

Maka VV, Pancha H, Shukla SN, Talati SS, Shah PM, Patel KM, Anand AS, Shah SA, Patel AA, Parikh S.

Gulf J Oncolog. 2016 Jan;1(20):38-44.

PMID:
27050178
15.

Triple-negative breast cancer survival in Iranian patients.

Aghili M, Lashkari M, Farrokhpey AH, Izadi S.

Acta Med Iran. 2013 Sep 9;51(8):560-6.

16.

Outcomes of Triple-Negative Breast Cancers (TNBC) Compared with Non-TNBC: Does the Survival Vary for All Stages?

Agarwal G, Nanda G, Lal P, Mishra A, Agarwal A, Agrawal V, Krishnani N.

World J Surg. 2016 Jun;40(6):1362-72. doi: 10.1007/s00268-016-3422-4.

PMID:
26842691
17.

Current strategy for triple-negative breast cancer: appropriate combination of surgery, radiation, and chemotherapy.

Yagata H, Kajiura Y, Yamauchi H.

Breast Cancer. 2011 Jul;18(3):165-73. doi: 10.1007/s12282-011-0254-9. Epub 2011 Feb 3. Review. Erratum in: Breast Cancer. 2012 Oct;19(4):369.

PMID:
21290263
18.

Impact of triple-negative breast cancer phenotype on prognosis in patients with stage I breast cancer.

Kim JE, Ahn HJ, Ahn JH, Yoon DH, Kim SB, Jung KH, Gong GY, Kim MJ, Son BH, Ahn SH.

J Breast Cancer. 2012 Jun;15(2):197-202. doi: 10.4048/jbc.2012.15.2.197. Epub 2012 Jun 28.

19.

Classical CMF regimen as adjuvant chemotherapy for triple-negative breast cancer may be more effective compared with anthracycline or taxane-based regimens.

Wang S, Shi Y, Yuan Z, Wang X, Liu D, Peng R, Teng X, Qin T, Peng J, Lin G, Jiang X.

Med Oncol. 2012 Jun;29(2):547-53. doi: 10.1007/s12032-011-9964-2. Epub 2011 Apr 29.

PMID:
21528408
20.

Supplemental Content

Support Center